TMEM218 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.255050E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.743200E-01
Normal-vs-Stage2
1.307780E-01
Normal-vs-Stage3
9.174500E-02
Normal-vs-Stage4
3.732800E-01
Stage1-vs-Stage2
2.082000E-01
Stage1-vs-Stage3
6.740200E-02
Stage1-vs-Stage4
9.350600E-01
Stage2-vs-Stage3
1.945400E-01
Stage2-vs-Stage4
3.307800E-01
Stage3-vs-Stage4
9.945700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.490760E-01
Normal-vs-AfricanAmerican
3.791800E-01
Normal-vs-Asian
3.485000E-03
Caucasian-vs-AfricanAmerican
5.563200E-01
Caucasian-vs-Asian
5.773900E-02
AfricanAmerican-vs-Asian
4.200100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
5.704400E-02
Normal-vs-Female
2.471800E-01
Male-vs-Female
1.166380E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.870620E-01
Normal-vs-Age(41-60Yrs)
3.586800E-01
Normal-vs-Age(61-80Yrs)
4.673500E-02
Normal-vs-Age(81-100Yrs)
3.010200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.984800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.195000E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.226400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.815300E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
8.403400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.011600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.745800E-01
Normal-vs-Daily Drinker
1.449970E-01
Normal-vs-Weekly Drinker
3.452300E-02
Normal-vs-Occasional Drinker
1.557750E-01
Normal-vs-Social Drinker
1.111240E-01
Non Drinker-vs-Daily Drinker
9.022000E-01
Non Drinker-vs-Weekly Drinker
4.303200E-01
Non Drinker-vs-Occasional Drinker
8.540000E-01
Non Drinker-vs-Social Drinker
7.048800E-01
Daily Drinker-vs-Weekly Drinker
5.029600E-01
Daily Drinker-vs-Occasional Drinker
7.263200E-01
Daily Drinker-vs-Social Drinker
6.016000E-01
Weekly Drinker-vs-Occasional Drinker
2.934400E-01
Weekly Drinker-vs-Social Drinker
1.869160E-01
Occasional Drinker-vs-Social Drinker
8.580600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.072360E-01
Normal-vs-Grade 2
3.990000E-02
Normal-vs-Grade 3
9.533800E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.908990E-01
Grade 1-vs-Grade 3
3.243700E-02
Grade 1-vs-Grade 4
1.072360E-01
Grade 2-vs-Grade 3
1.652160E-01
Grade 2-vs-Grade 4
3.990000E-02
Grade 3-vs-Grade 4
9.533800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
5.322300E-02
Normal-vs-NonDiabetic
1.465010E-01
Diabetic-vs-NonDiabetic
3.658800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.203600E-01
Normal-vs-NoPancreatitis
1.288590E-01
Pancreatitis-vs-NoPancreatitis
4.540000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.419600E-02
Normal-vs-N1
1.563560E-01
N0-vs-N1
6.698000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.980010E-01
Normal-vs-TP53-NonMutant
1.090000E-01
TP53-Mutant-vs-TP53-NonMutant
3.443800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
